SEC Form 4 · accession 0001140361-16-069461
Asterias Biotherapeutics, Inc. · AST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alfred D Kingsley
Director
Period of report
Jun 9, 2016
Accepted (ET)
Jun 10, 2016 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001572552
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 9, 2016 | P | 4,000 | $2.93 | A | 9,000 | D |
Table II — derivative securities
No Table II lines on this filing.